|
BRCA-like classification in ovarian cancer: Results from the AGO-TR1-trial. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Roche/Genentech |
Consulting or Advisory Role - Roche/Genentech |
Travel, Accommodations, Expenses - PharmaMar |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Olympus; Roche |
Travel, Accommodations, Expenses - AstraZeneca; Olympus |
|
|
Honoraria - AstraZeneca; Medac; MSD; Novartis; PharmaMar; Roche |
Consulting or Advisory Role - AstraZeneca; MSD; PharmaMar; Roche |
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Roche |
Travel, Accommodations, Expenses - Celgene; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Fujirebio Diagnostics; Myriad Genetics; Roche |
Consulting or Advisory Role - Fujirebio Diagnostics; Glycotope GmbH |
Research Funding - Takeda; Tesaro |
Travel, Accommodations, Expenses - GlaxoSmithKline; Myriad Genetics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca |
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Roche (Inst) |
Patents, Royalties, Other Intellectual Property - N/A Patent pending on BRCAess classifer (Inst) |
Travel, Accommodations, Expenses - Pfizer; Roche |
|
|
|
|
|
Honoraria - AstraZeneca; Roche |
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Sotio; Tesaro |
Travel, Accommodations, Expenses - Medac |
|
|
|